GW0742 is a PPAR-delta agonist structurally related to Cardarine (GW-501516), studied in preclinical research for similar endurance and metabolic effects. It has an even smaller published research base than Cardarine and has not been through human clinical trials.
Same drug class as Cardarine — same category of concern
GW0742 is a PPAR-δ (delta) agonist — the same receptor target as Cardarine (GW-501516), which was discontinued after showing tumor-promotion in long-term rodent toxicology studies (see Cardarine's page for the details and citations). A published case report specifically documents poisoning from a combination of GW1516 (Cardarine) and MK2866 (Ostarine) taken together, underscoring this drug class carries real, documented human harm potential, not just theoretical risk. PMC8538264 No dedicated human trial of GW0742 itself was found — given the shared mechanism with Cardarine, the same cancer-risk caution applies until proven otherwise, not assumed safer by default.
Is GW0742 the same as Cardarine?+
No, but the two are closely related PPAR-delta agonists from the same research program, studied for similar metabolic effects.
Is GW0742 safer than Cardarine?+
That is not established. It has far less published research than Cardarine, including no completed long-term safety studies, so any safety comparison is speculative rather than evidence-based.
Is GW0742 FDA-approved?+
No, it is not an approved drug and has no completed human trials.
Looking for something specific, or placing a wholesale order? Send us a DM or email.